Kelu Zhou
- Ophthalmology top 0.5%
- Retinal Diseases and Treatments 20
- Glaucoma and retinal disorders 6
- Clinical Biochemistry top 5%
- Advanced Glycation End Products research 5
- Neurology top 10%
- Cancer Research top 10%
- Cancer, Hypoxia, and Metabolism 4
-
- Retinal Imaging and Analysis 5
-
- Peroxisome Proliferator-Activated Receptors 8
- Wnt/β-catenin signaling in development and cancer 7
- Retinal Development and Disorders 5
- Co-authors
- Jian‐xing MaYang HuYing ChenFangfang QiuTi ZhouBin ZhangKyoungmin ParkYusuke Takahashi
- Journals
- Diabetes (7 papers)Investigative Ophthalmology & Visual Science (7 papers)American Journal Of Pathology (3 papers)
- Partner nations
- United StatesChinaFrance
In The Last Decade
Kelu Zhou
33 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 96
- Ophthalmology 684
- Clinical Biochemistry 143
- Neurology 123
- Cancer Research 219
- Radiology, Nuclear Medicine and Imaging 303
Countries citing papers authored by Kelu Zhou
This map shows the geographic impact of Kelu Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kelu Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kelu Zhou more than expected).
Fields of papers citing papers by Kelu Zhou
This network shows the impact of papers produced by Kelu Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kelu Zhou. The network helps show where Kelu Zhou may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Kelu Zhou, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2026 | 0 | |
| 2 | 2025 | 1 | |
| 3 | 2022 | 9 | |
| 4 | 2019 | 35 | |
| 5 | 2019 | 96 | |
| 6 | 2018 | 9 | |
| 7 | 2017 | 6 | |
| 8 | 2017 | 42 | |
| 9 | 2017 | 31 | |
| 10 | 2016 | 8 | |
| 11 | 2014 | 25 | |
| 12 | 2013 | 84 | |
| 13 | Mechanisms for the Therapeutic Effect of Fenofibrate on Diabetic Retinopathy in Type 1 Diabetes Models | 2011 | 1 |
| 14 | 2011 | 69 | |
| 15 | 2011 | 110 | |
| 16 | Cyp2c8 variant reduce the therapeutic response to thiazolidinediones - a godarts study | 2010 | 3 |
| 17 | 2010 | 90 | |
| 18 | 2010 | 80 | |
| 19 | 2009 | 133 | |
| 20 | 2009 | 44 |
About Kelu Zhou
Kelu Zhou is a scholar working on Ophthalmology, Clinical Biochemistry and Physiology, having authored 35 papers that have together received 1.5k indexed citations. Recurring topics across this work include Retinal Diseases and Treatments (20 papers), Peroxisome Proliferator-Activated Receptors (8 papers), Wnt/β-catenin signaling in development and cancer (7 papers), Glaucoma and retinal disorders (6 papers), Retinal Imaging and Analysis (5 papers), Retinal Development and Disorders (5 papers), Advanced Glycation End Products research (5 papers) and Cancer, Hypoxia, and Metabolism (4 papers). The work is most often cited by research in Ophthalmology (684 citations), Clinical Biochemistry (143 citations) and Neurology (123 citations). Kelu Zhou has collaborated with scholars based in United States, China and France. Frequent co-authors include Jian‐xing Ma, Yang Hu, Ying Chen, Fangfang Qiu, Ti Zhou, Bin Zhang, Kyoungmin Park, Yusuke Takahashi, Guoquan Gao and Timothy J. Lyons. Their work appears in journals such as Diabetes, Investigative Ophthalmology & Visual Science, American Journal Of Pathology, Diabetologia and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.